{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:47:54Z","timestamp":1760204874580},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6969","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T18:18:05Z","timestamp":1475259485000},"page":"2877-2880","source":"Crossref","is-referenced-by-count":7,"title":["Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor \u03b1 Inhibitor Treatment"],"prefix":"10.2169","volume":"55","author":[{"given":"Takahiro","family":"Takazono","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyomitsu","family":"Sawai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nagasaki Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Saijo","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Imamura","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiga","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naofumi","family":"Suyama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nagasaki Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kakeya","sequence":"additional","affiliation":[{"name":"Department of Infection Control Science, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Yanagihara","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Morrison VA. Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies. Clin Infect Dis 59 Suppl 5: S360-S364, 2014.","DOI":"10.1093\/cid\/ciu592"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Takazono T, Izumikawa K, Yoshioka S, et al. Possible pulmonary cryptococcosis in a patient with Crohn&apos;s disease during anti-tumor necrosis factor-alpha treatment: a case report and literature review. Jpn J Infect Dis 65: 461-464, 2012.","DOI":"10.7883\/yoken.65.461"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 50: 291-322, 2010.","DOI":"10.1086\/649858"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Vibhagool A, Sungkanuparph S, Mootsikapun P, et al. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Clin Infect Dis 36: 1329-1331, 2003.","DOI":"10.1086\/374849"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kohno S, Kakeya H, Izumikawa K, et al. Clinical features of pulmonary cryptococcosis in non-HIV patients in Japan. J Infect Chemother 21: 23-30, 2015.","DOI":"10.1016\/j.jiac.2014.08.025"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64: 625-639, 2012.","DOI":"10.1002\/acr.21641"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bicanic T, Harrison T, Niepieklo A, Dyakopu N, Meintjes G. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis 43: 1069-1073, 2006.","DOI":"10.1086\/507895"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Garcia Vidal C, Rodriguez Fern\u00e1ndez S, Mart\u00ednez Lacasa J, et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 40: 756-759, 2005.","DOI":"10.1086\/427941"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Moureau C, Pothen L, Wilmes D, Yombi JC, Coche E, Hainaut P. Paradoxical response to tuberculosis treatment in a patient receiving tumor necrosis factor-alpha antagonist. Am J Med 125: e9-e10, 2012.","DOI":"10.1016\/j.amjmed.2012.02.006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 38: 1159-1166, 2004.","DOI":"10.1086\/383034"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shelburne SA 3rd, Darcourt J, White AC Jr, et al. The role of immune reconstitution inflammatory syndrome in AIDS-related <i>Cryptococcus neoformans<\/i> disease in the era of highly active antiretroviral therapy. Clin Infect Dis 40: 1049-1052, 2005.","DOI":"10.1086\/428618"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/19\/55_55.6969\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:06:49Z","timestamp":1498334809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/19\/55_55.6969\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":11,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6969","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}